The Precision Medicine Company

Developing microbiome-based predictive diagnostic and companion therapeutic products to enable safer and more efficacious drug therapies

AlphaBiomics selected to pitch at two investor events (organised by P4 and BioCity).

Read more here.

NIHR_Logos_Funded by_COL_CMYK

The Precision Medicine Company

Developing microbiome-based predictive diagnostic and companion therapeutic products to enable safer and more efficacious drug therapies

Winner of the 2018 European Innovation Quickfire Challenge (read more)